The Odisha government announced the Pharmaceutical and Medical Devices Policy-2025, with the objective of drawing an investment of Rs.25,000 crore and generating 1 lakh jobs by 2030.

Chief Minister Mohan Charan Majhi unveiled the new policy at the Odisha Pharma Summit-2025, attended by Industries Minister Sampad Chandra Swain and senior government officials.

On the occasion, Hemant Sharma, Additional Chief Secretary of the Industries Department, noted that India imports nearly 85 percent of its medical devices from abroad, indicating a significant opportunity in this sector.

Sharma stated that with numerous pharmaceutical and medical device units anticipated to emerge in the next five years, Odisha should strive to be involved in this effort.

According to the policy, the state provides a 50 percent subsidy on the concessional cost of land for units that hire over 200 skilled workers from Odisha.

Reports indicate that the government provided a 30 percent capital subsidy on qualifying plant and machinery (distributed at up to 6 percent annually for 5 years), with no maximum limit, whereas a 25 percent subsidy (limited to Rs.1 crore) will be available for dedicated power infrastructure.

He stated that the goal of the new policy is to expedite Odisha's emergence as the eastern center for pharmaceuticals and medical devices by fostering investment, creating jobs, encouraging innovation, and promoting green manufacturing.

Also Read: Semicon India 2025: Designing A Self-Reliant Semiconductor Hub

"The policy is anticipated to attract an investment of Rs."By 2030, he stated, it will be 25,000 crore and create direct and indirect jobs for 1 lakh people."

The policy seeks to draw investment and stimulate local entrepreneurship and MSME development, while also creating jobs in skilled and semi-skilled areas.

Also Read: The Global Fintech Fest 2025: Enabling Finance for Better World

Grounded in the state's Industrial Policy Resolution (IPR) 2022, which recognizes pharmaceuticals, bulk drugs, and medical devices as a key sector, the policy encourages infrastructure preparedness, research prowess, collaboration between industry and academia for skill development, and a supportive regulatory framework to foster inclusive and sustainable industrial growth, stated another official.

The government will establish an Odisha Pharma Park and an Odisha MedTech Park (each over 200 acres) as integrated clusters prepared for good manufacturing practices (GMP), he stated.

Also Read: 5 AI Initiatives by the Indian Government Driving National Growth

The strategy integrates land, funding, a skilled labor force, regulatory support, and R&D assistance to draw key investments in active pharmaceutical ingredients (APIs), formulations, vaccines, diagnostics, imaging, implants, and wearables, establishing Odisha as a competitive and sustainable hub for manufacturing and innovation.